Ofer Levy

20.6k total citations · 4 hit papers
215 papers, 13.2k citations indexed

About

Ofer Levy is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ofer Levy has authored 215 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Immunology, 48 papers in Pulmonary and Respiratory Medicine and 45 papers in Epidemiology. Recurrent topics in Ofer Levy's work include Immune Response and Inflammation (84 papers), Neonatal Respiratory Health Research (46 papers) and Immune responses and vaccinations (33 papers). Ofer Levy is often cited by papers focused on Immune Response and Inflammation (84 papers), Neonatal Respiratory Health Research (46 papers) and Immune responses and vaccinations (33 papers). Ofer Levy collaborates with scholars based in United States, Australia and Italy. Ofer Levy's co-authors include David J. Dowling, Tobias R. Kollmann, Hagit Achdout, Ofer Mandelboim, Zurit Levine, Amir Toporik, Amit Novik, Liat Dassa, Noa Stanietsky and Hrvoje Šimić and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ofer Levy

208 papers receiving 12.8k citations

Hit Papers

The interaction of TIGIT ... 2007 2026 2013 2019 2009 2007 2012 2017 500 1000 1.5k 2.0k 2.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ofer Levy 6.1k 2.7k 2.2k 2.1k 1.7k 215 13.2k
David M. Ojcius 4.9k 0.8× 2.7k 1.0× 8.8k 4.1× 785 0.4× 1.6k 1.0× 299 19.8k
Robert A. Clark 8.7k 1.4× 1.7k 0.6× 5.7k 2.6× 1.8k 0.9× 1.4k 0.8× 538 24.5k
William Cookson 3.8k 0.6× 2.0k 0.7× 7.3k 3.4× 3.6k 1.7× 845 0.5× 191 21.7k
Thomas Lehner 4.4k 0.7× 3.2k 1.2× 4.9k 2.3× 1.5k 0.7× 1.6k 1.0× 377 20.1k
Li Liu 2.7k 0.4× 3.7k 1.4× 5.3k 2.4× 1.9k 0.9× 3.6k 2.2× 586 20.5k
Gil Mor 10.2k 1.7× 3.1k 1.2× 5.8k 2.7× 1.5k 0.7× 965 0.6× 342 22.7k
Sabra L. Klein 4.1k 0.7× 3.6k 1.4× 2.0k 0.9× 837 0.4× 5.3k 3.2× 204 20.7k
Hywel C Williams 2.5k 0.4× 3.7k 1.4× 1.5k 0.7× 1.5k 0.7× 1.1k 0.7× 630 36.2k
Dominic Kwiatkowski 6.3k 1.0× 3.0k 1.1× 4.3k 2.0× 841 0.4× 1.8k 1.1× 326 22.3k
H. Hugh Fudenberg 9.5k 1.5× 2.4k 0.9× 4.5k 2.1× 1.6k 0.8× 970 0.6× 653 22.1k

Countries citing papers authored by Ofer Levy

Since Specialization
Citations

This map shows the geographic impact of Ofer Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Levy more than expected).

Fields of papers citing papers by Ofer Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Levy. The network helps show where Ofer Levy may publish in the future.

Co-authorship network of co-authors of Ofer Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Levy. A scholar is included among the top collaborators of Ofer Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Levy. Ofer Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelidou, Asimenia, Amy C Sherman, Cameron McLoughlin, et al.. (2025). Product and trial design considerations on the path towards a vaccine to combat opioid overdose. npj Vaccines. 10(1). 35–35. 2 indexed citations
3.
Amodio, Donato, Asimenia Angelidou, Nicola Cotugno, et al.. (2024). Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine. 43(Pt 2). 126477–126477.
4.
Brook, Byron, Valérie Duval, Soumik Barman, et al.. (2024). Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70. Science Translational Medicine. 16(757). eadm8451–eadm8451. 19 indexed citations
5.
Viodé, Arthur, Kinga K. Smolen, Patrick van Zalm, et al.. (2024). Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes. Science Advances. 10(21). eadl5762–eadl5762. 11 indexed citations
6.
Nanishi, Etsuro, et al.. (2023). Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations. Pharmaceutics. 15(6). 1766–1766. 8 indexed citations
7.
Guise, Amanda J., Tojo Nakayama, Christoph N. Schlaffner, et al.. (2023). Integrative systems biology characterizes immune-mediated neurodevelopmental changes in murine Zika virus microcephaly. iScience. 26(7). 106909–106909. 3 indexed citations
8.
Viodé, Arthur, Patrick van Zalm, Kinga K. Smolen, et al.. (2023). A simple, time- and cost-effective, high-throughput depletion strategy for deep plasma proteomics. Science Advances. 9(13). eadf9717–eadf9717. 48 indexed citations
9.
Kelly, Rachel S., Su H. Chu, Priyadarshini Kachroo, et al.. (2023). Elevated third trimester corticosteroid levels are associated with fewer offspring infections. Scientific Reports. 13(1). 10461–10461. 1 indexed citations
10.
Nanishi, Etsuro, Ofer Levy, & Al Ozonoff. (2022). Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review. Human Vaccines & Immunotherapeutics. 18(5). 2045857–2045857. 24 indexed citations
11.
Top, Karina A., Robert T. Chen, Ofer Levy, et al.. (2022). Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clinical Infectious Diseases. 75(Supplement_1). S11–S17. 12 indexed citations
12.
Gutcher, Ilona, Wolf‐Dietrich Doecke, Merlin V. Luetke-Eversloh, et al.. (2020). Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunology Research. 8(7). 895–911. 7 indexed citations
13.
Pan, Xiaoyu, Eran Ophir, Zoya Alteber, et al.. (2019). Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity. Cancer Immunology Research. 7(2). 244–256. 45 indexed citations
14.
Whelan, Sarah, Eran Ophir, Maya F. Kotturi, et al.. (2019). PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function. Cancer Immunology Research. 7(2). 257–268. 125 indexed citations
15.
Cotugno, Nicola, Alessandra Ruggiero, Veronica Santilli, et al.. (2019). OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines. Journal of Immunology Research. 2019. 1–10. 24 indexed citations
16.
Dowling, David J., Evan A. Scott, Annette Scheid, et al.. (2017). Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. Journal of Allergy and Clinical Immunology. 140(5). 1339–1350. 108 indexed citations
17.
Lapidot, Rotem, et al.. (2017). Hepatic Legionella pneumophila Infection in an Infant With Severe Combined Immunodeficiency. The Pediatric Infectious Disease Journal. 37(4). 356–358. 2 indexed citations
18.
Levy, Ofer, et al.. (2006). The Adenosine System Selectively Inhibits TLR-Mediated TNF-α Production in the Human Newborn. The Journal of Immunology. 177(3). 1956–1966. 191 indexed citations
19.
Canny, G., Ofer Levy, Glenn T. Furuta, et al.. (2002). Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proceedings of the National Academy of Sciences. 99(6). 3902–3907. 242 indexed citations
20.
Juran, Ilan, et al.. (1998). Recent developments in soil-nailing - Design & practice. 259–284. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026